Q2 2024 Bristol-Myers Squibb Co Earnings Call
Insightful Analysis of BMY's Strengths, Weaknesses, Opportunities, and Threats
Bristol Myers Squibb stock gapped higher Friday after the Big Pharma stalwart beat June-quarter forecasts and raised its outlook.